Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China Pharma Holdings (CPHI) Beginning Cash Balance (2017 - 2022)

China Pharma Holdings filings provide 9 years of Beginning Cash Balance readings, the most recent being -$4026.0 for Q4 2022.

  • On a quarterly basis, Beginning Cash Balance fell 101.3% to -$4026.0 in Q4 2022 year-over-year; TTM through Dec 2022 was $223013.0, a 60.36% decrease, with the full-year FY2022 number at $223013.0, down 60.36% from a year prior.
  • Beginning Cash Balance hit -$4026.0 in Q4 2022 for China Pharma Holdings, up from -$4317.0 in the prior quarter.
  • In the past five years, Beginning Cash Balance ranged from a high of $310783.0 in Q4 2021 to a low of -$4850.0 in Q2 2022.
  • Median Beginning Cash Balance over the past 4 years was $111691.0 (2019), compared with a mean of $102821.2.
  • Biggest five-year swings in Beginning Cash Balance: surged 172.36% in 2021 and later crashed 28880.0% in 2022.
  • China Pharma Holdings' Beginning Cash Balance stood at $111691.0 in 2019, then grew by 2.16% to $114109.0 in 2020, then skyrocketed by 172.36% to $310783.0 in 2021, then plummeted by 101.3% to -$4026.0 in 2022.
  • The last three reported values for Beginning Cash Balance were -$4026.0 (Q4 2022), -$4317.0 (Q3 2022), and -$4850.0 (Q2 2022) per Business Quant data.